Health Care

2492 posts
doctor pointing finger to CT scans

Quantum BioPharma sues CIBC and RBC seeking $700M in damages

A U.S. legal firm claims it has evidence of a market manipulation scheme that caused substantial damages to Quantum BioPharma (CSE:QNTM).
WELL Health founder and CEO Hamed Shahbazi, centre.

WELL subsidiary launches support for women’s hormonal imbalance

WELL Health (TSX:WELL) subsidiary Wisp, the United States' largest dedicated women's telehealth provider, launches a weight care vertical.
Stock image generated with AI

Buzz on the Bullboards: Stocks to watch as TSX hits new highs

The TSX experienced a roller-coaster of wins and losses this week, yet managed to break a record high with three companies standing out.
image of scientist looking into a microscope

BriaCell Therapeutics advances Phase 3 MBC clinical study

BriaCell Therapeutics (TSX:BCT) advances its Phase 3 study of Bria-IMT patients with metastatic breast cancer.
AI healthcare technology

The 10 best AI healthcare stocks to watch

Read about the strong contingent of healthcare stocks keen on applying AI technology to improve patient outcomes.
Pawns and arrows

Three Canadian small-caps stocks for a contrarian investment

The Canadian market, like any other, reflects value in stock prices over the long term but often gets it wrong with small-cap stocks.
hand writing pain relief with sharpie

An investor’s opportunity in injectable liposomal CBD’s potential

Innocan Pharma (CSE:INNO) has developed LPT-CBD to address the unmet need for safe and effective chronic pain relief.
  • Research
  • 5 mins
  • 10 October 2024 07:00 (EDT)
doctor holding palm of hand out with bladder cancer sign

Latest data from bladder cancer study to propel future growth 

Theralase Technologies (TSXV:TLT) is developing small molecule drugs able to specifically target and destroy cancer cells.
Healthcare workers walking in a hospital.

VitalHub acquires MedCurrent Corp. for $12 million

Healthcare stock VitalHub (TSX:VHI) closes its acquisition of MedCurrent Corp. in an all-cash transaction for C$12 million.
Cancer cells being destroyed by immunotherapy.

How BioVaxys’ DPX platform creates anti-cancer immune response

Discover BioVaxys' innovative DPX platform, a cutting-edge lipid-based delivery system transforming immunotherapy.
  • Research
  • 1 min
  • 08 October 2024 07:00 (EDT)
Medical technician looking into a microscope

Theralase’s bladder cancer drug under investigation in clinical study

Pharma stock Theralase Technologies (TSXV:TLT) announces a significant update on its ongoing bladder cancer clinical study.
Visible gold from Northstar Gold's Miller gold property in Ontario

Three high-quality micro-cap stocks for your coffee-can portfolio

High-quality micro-cap stocks are best buried in coffee cans in your back yard and forgotten for a very long time.
(Stock image generated with AI)

One of the best Venture pharma stocks has grown even stronger

Voyageur Pharmaceuticals (TSXV:VM) has made significant strides with the approval of five new formulations by Health Canada.
A lab technician doing a medical study

PharmAla to supply Harvard Medical School trial with MDMA

PharmAla Biotech (CSE:MDMA) has been contracted as a supplier of MDMA to a clinical trial at Harvard’s Maclean Hospital.
A.I. generated image of health care investing

Buzz on the Bullboards: TSX stocks making headlines this week

The TSX experienced a dynamic week. It opened flat Monday, but saw a significant jump Tuesday driven by an increase in commodity prices.
Travel insurance photo illustration of a globe, airliner, passport and stethoscope.

Many Canadians plan to scrimp on travel insurance, survey shows

Many Canadians planning to travel are cutting costs, including foregoing travel insurance, according to a survey from TD Insurance.
Avicanna, MyMedi.ca, The Canadian Pain Society and the Canadian Consortium for the Investigation of Cannabinoids

Avicanna announces medical cannabis study through MyMedi.ca  

Avicanna Inc. (TSX:AVCN) plans a large-scale medical cannabis real world evidence study through the MyMedi.ca medical cannabis care platform.
healthcare worker holding pink ribbon representing breast cancer awareness

Oncolytics Biotech reports positive results from breast cancer study

Oncolytics Biotech (TSX:ONC) revealed results from its Phase 2 study in patients with advanced or metastatic breast cancer.
An AI generated photo of a stethoscope on a computerized setting

BioPharma Services expands to late-stage patient trials via AI platform

BioPharma Services, a Healwell AI (TSX:AIDX) subsidiary specializing in early-phase clinical trials, is moving into late stage patient trials
Redecan cannabis products

Tilray expands Redecan into Australia’s medical cannabis market

Tilray Brands (TSX:TLRY) subsidiary, Tilray Medical, launches Redecan-branded medical cannabis in Australia.